Nurix Therapeutics, Inc. · NASDAQ:NRIX
Commodore Capital LP's stake in Nurix Therapeutics, Inc. fell to 4.90% (Schedule 13G/A)
Event Sep 30, 2025 · Filed Nov 14, 2025
Commodore Capital LP's stake in Nurix Therapeutics, Inc. fell to 4.90%, 3,780,055 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G/A).
- Stake
- 4.90%
- Shares
- 3,780,055
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Commodore Capital LP | 4.90% | 3,780,055 |
| Commodore Capital Master LP | 4.90% | 3,780,055 |
Source
Related
- Nurix Therapeutics, Inc.
- Commodore Capital LP
- Nurix Therapeutics, Inc. shareholders
- Schedule 13G · Commodore Capital LP · Feb 14, 2025
- Form 4 · Hansen Gwenn · Oct 15, 2026
- Form 4 · Gregory Julia P · Oct 14, 2026
- Form 4 · Ring Christine · Oct 2, 2026
- Schedule 13G · Perceptive Advisors LLC · Sep 23, 2026
- Form 4 · Ring Christine · Sep 2, 2026